ASX Share rice
Wed 05 Aug 2020 - 12:07:am (Sydney)

RAC Share Price

RACE ONCOLOGY LTDRACPharmaceuticals, Biotechnology & Life Sciences

RAC Company Information

Name:

Race Oncology Limited

Sector:

Healthcare

Industry:

Biotechnology

GIC Industry:

Biotechnology

GIC Sub Industry:

Biotechnology

Address:

140 William Street Melbourne VIC Australia 3000

Phone:

61 3 9097 1656

Exec. Chairman:

Dr. John Cullity

COO & Non-Exec. Director:

Dr. Daniel Tillett

Company Sec.:

Mr. Peter Gordon Webse M.A.I.C.D., B.Bus, FGIA, FCIS, FCPA, MAICD

Company Overview:

Race Oncology Limited operates as a specialty pharmaceutical company in Australia. It is developing Bisantrene, a small molecule cancer chemotherapy drug that is used for the treatment of acute myeloid leukaemia. The company was formerly known as Coronado Resources Limited and changed its name to Race Oncology Limited in July 2016. Race Oncology Limited was incorporated in 2011 and is based in Melbourne, Australia.

RAC Share Price Information

Shares Issued:

115.59M

Market Capitalisation:

$101.72M

Revenue (TTM):

$159.37K

Revenue Per Share (TTM):

$0

Earnings per Share:

$-0.046

Operating Margin (TTM):

$-19.67

Return On Assets (TTM):

$-0.32

Return On Equity (TTM):

$-0.53

Quarterly Revenue Growth (YOY):

-0.303

Gross Profit(TTM):

$-303,986

Diluted Earnings Per Share (TTM):

$-0.035

RAC CashFlow Statement

CashFlow Date:

2019-06-30

Change To Liabilities:

$-117,588

Net Income:

$-3,659,402

Total Cash From Operating Activities:

$-2,674,002

Depreciation:

$281.20K

Change To Account Receivables:

$-181

Sale Purchase Of Stock:

$-33,842

Capital Expenditures:

$0

RAC Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-3,659,402

Net Income:

$-3,659,402

Gross Profit:

$-303,986

Operating Income:

$-3,905,258

Other Operating Expenses:

$143.21K

Total Revenue:

$228.50K

Total Operating Expenses:

$3.91M

Cost Of Revenue:

$532.49K

RAC Balance Sheet

Balance Sheet Date:

2019-06-30

Intangible Assets:

$4.22M

Total Liabilities:

$192.12K

Total Stockholder Equity:

$5.05M

Other Current Liabilities:

$33.75K

Total Assets:

$5.24M

Common Stock:

$15.42M

Other Current Assets:

$34.76K

Retained Earnings:

$-13,427,712

Cash:

$0.99M

Total Current Liabilities:

$192.12K

Net Tangible Assets:

$831.97K

Total Current Assets:

$1.02M

Net Receivables:

$611

Short-Term Investments:

$4.22M

Accounts Payable:

$100.15K

Non Currrent Assets (Other):

$4.22M

Short-Term Investments:

$4.22

Non Current Liabilities Total:

$0

RAC Share Price History

RAC News

22 Nov, 2019
It is a pleasure to report that the Race Oncology Limited (ASX:RAC) is up 47% in the last quarter. But that doesn't...